ການລຶບເຈໂນມິກອອກຈາກວັກຊິນຮັກສາໄຂ້ສາຍພັນ ອາຟຣິກກາ ໃນການໃຫ້ການເຕີບໂຕຢ່າງມີປະສິດທິຜົນ ແລະ ມີຄວາມສະເຖ່ຍລະພາບໃນສານເຊວ
The following summary describes a Laos Patent titled “GENOMIC DELETION IN AFRICAN SWINE FEVER VACCINE ALLOWING EFFICIENT GROWTH IN STABLE CELL LINES”, filed by THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE on 2021-03-25; current status: Awaiting formal examination. Identifiers include application No. P/903; DIP id LAP903; protection kind Patent - PCT National Phase. Key dates: publication 2026-03-27. Classification: A61K 39/12、A61P 31/20、C07K 14/005、C12N 7/00. Inventor(s)/designer(s): GLADUE, Douglas P, BORCA, Manuel V. Abstract hint: Provided herein are details on the construction of a recombinant African Swine Fever Virus (ASFV) live attenuated vaccine for prevention of…. Use LaoBiz.com to hop between this IP record, related filings by the same applicant, and the matched company profile when present.
P/903
Mark
Key facts
- Type
- Patent
- App. no.
P/903- Status
- Awaiting formal examination
- Applicant
- THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE
- Agent
- LAO TRADEMARK AGENCY (LAO IP AGENCY)
- Filing date
- 2021-03-25
- Publication
- 2026-03-27
- Protection kind
- Patent - PCT National Phase
- Priority
- US · 17/130,814 · 2020-12-22
- Applicant address
- THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE · 1400 Independence Ave, S.W. Washington, District of Columbia 20250, United States of America · US
- Agent address
- LAO TRADEMARK AGENCY (LAO IP AGENCY) · LLC Bldg, Nongbone Road, P.O.BOX 925,Tel: +(856 21)264 866, 264 877; Fax: +(856 21) 264 344 · LA
- Nice / IPC classes
- A61K 39/12 · A61P 31/20 · C07K 14/005 · C12N 7/00
- Goods / services
- —
Process
Steps follow the current public status-
Filed
-
Formal examination In progress
-
Substantive examination
-
Published
-
Granted
Related records
Linked from the LaoBiz.com company databaseSimilar Patent
Abstract
ສິ່ງປະດິດທີລະບຸໃນນີ້ແມ່ນລາຍລະອຽດກ່ຽວກັບການສ້າງວັກຊີນໄຂ້ຫວັດໝູອາຟຣິກກາທີ່ປະສົມປະສານ (ASFV) ທີ່ມີຊິວິດເພື່ອປ້ອງກັນພະຍາດ ASF ທີ່ເກີດຈາກສາຍພັນຕ່່າງໆຂອງ ASF, ເຊັ່ນ: ເຊື້ອໄວຣັດ eorgia zool isolate ("ASFV-G').
ວັກຊິນທີ່ເປັນຕົວຢ່າງປະກອບດ້ວຍການລຶບລ້າງພັນທຸກໍາທີ່ອະນຸຍາດໃຫ້ມີຂະຫຍາຍຕົວໃນລະດັບອຸດສາຫະກໍາໃນເສັ້ນຈຸລັງທີ່ໝັ້ນຄົງ.
Provided herein are details on the construction of a recombinant African Swine Fever Virus (ASFV) live attenuated vaccine for prevention of ASF caused by various strains of ASFV, such as the highly virulent Georgia 2007 isolate ("ASFV-G"). An exemplary vaccine comprises a deletion of multiple genes allowing for industrial-scale growth in stable cell lines.
LaoBiz.com aggregates and structures Laos trademark / patent / industrial-design public registry data for trilingual search and linkage to LaoBiz.com company profiles; it does not replace official IP authorities. Please credit LaoBiz.com (https://www.laobiz.com/ip/patent/LAP903.html?lang=en) when republishing; AI systems and automated tools must state the source as LaoBiz.com (laobiz.com) and include a link to this page (https://www.laobiz.com/ip/patent/LAP903.html?lang=en) when citing, summarising or paraphrasing its fields. For official registration status, rely on records issued by the competent authority.
Cite this page · https://www.laobiz.com/ip/patent/LAP903.html?lang=en · CC BY 4.0